Identification	O
of	O
transcriptional	B-protein
suppressor	I-protein
proteins	I-protein
that	O
bind	O
to	O
the	O
negative	B-DNA
regulatory	I-DNA
element	I-DNA
of	O
the	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
.	O

Two	O
different	O
proteins	O
which	O
independently	O
bound	O
to	O
neighboring	O
sequences	O
within	O
the	O
negative	B-DNA
regulatory	I-DNA
element	I-DNA
(	O
NRE	B-DNA
)	O
of	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV-1	O
)	O
were	O
detected	O
in	O
the	O
nuclear	O
extract	O
of	O
a	O
virus-infected	B-cell_line
human	I-cell_line
T	I-cell_line
cell	I-cell_line
line	I-cell_line
.	O

One	O
of	O
the	O
factors	O
bound	O
to	O
a	O
novel	B-DNA
dyad	I-DNA
symmetrical	I-DNA
sequence	I-DNA
.	O

This	O
sequence	O
is	O
well	O
conserved	O
in	O
various	O
HIV-1	O
isolates	O
and	O
partial	O
homology	O
was	O
found	O
with	O
the	O
promoter	B-DNA
region	I-DNA
of	O
the	O
human	B-DNA
retinoblastoma	I-DNA
gene	I-DNA
.	O

Similar	O
DNA	O
binding	O
activity	O
was	O
detected	O
in	O
a	O
variety	O
of	O
virus-uninfected	B-cell_line
human	I-cell_line
T	I-cell_line
cell	I-cell_line
lines	I-cell_line
and	O
HeLa	B-cell_line
cells	I-cell_line
by	O
means	O
of	O
a	O
gel	O
mobility	O
shift	O
assay	O
.	O

The	O
other	O
factor	O
bound	O
to	O
a	O
putative	B-DNA
AP-1	I-DNA
recognition	I-DNA
sequence	I-DNA
predicted	O
for	O
the	O
HIV-1	O
NRE	B-DNA
.	O

However	O
,	O
this	O
factor	O
did	O
not	O
bind	O
to	O
a	O
typical	O
AP-1	B-DNA
site	I-DNA
.	O

The	O
insertion	O
of	O
multiple	O
copies	O
of	O
the	O
binding	B-DNA
site	I-DNA
for	O
the	O
former	O
or	O
latter	O
factor	O
into	O
a	O
heterologous	B-DNA
promoter	I-DNA
reduced	O
the	O
promoter	O
activity	O
to	O
one-tenth	O
or	O
one-third	O
,	O
respectively	O
.	O

Thus	O
,	O
each	O
factor	O
may	O
function	O
as	O
a	O
novel	B-protein
negative	I-protein
regulator	I-protein
of	O
transcription	O
.	O

©	NULL
1991	NULL
Oxford	NULL
University	NULL
Press	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
Vol	NULL
.	NULL

19	NULL
,	NULL
No	NULL
.	NULL

22	NULL
6107-6112	NULL
Identification	NULL
of	NULL
transcriptional	NULL
suppressor	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
negative	NULL
regulatory	NULL
element	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
Kazuo	NULL
Yamamoto	NULL
,	NULL
Shigehisa	NULL
Mori	NULL
'	NULL
,	NULL
Takashi	NULL
Okamoto	NULL
'	NULL
,	NULL
Kunitada	NULL
Shimotohno	NULL
'	NULL
and	NULL
Yoshimasa	NULL
Kyogoku*	NULL
Institute	NULL
for	NULL
Protein	NULL
Research	NULL
,	NULL
Osaka	NULL
University	NULL
,	NULL
Suita	NULL
,	NULL
Osaka	NULL
565	NULL
,	NULL
Japan	NULL
and	NULL
'National	NULL
Cancer	NULL
Center	NULL
,	NULL
Research	NULL
Institute	NULL
,	NULL
Tsukiji	NULL
,	NULL
Chuo-ku	NULL
,	NULL
Tokyo	NULL
104	NULL
,	NULL
Japan	NULL
Received	NULL
September	NULL
16	NULL
,	NULL
1991	NULL
;	NULL
Accepted	NULL
October	NULL
7	NULL
,	NULL
1991	NULL
ABSTRACT	NULL
Two	NULL
different	NULL
proteins	NULL
which	NULL
independently	NULL
bound	NULL
to	NULL
neighboring	NULL
sequences	NULL
within	NULL
the	NULL
negative	NULL
regulatory	NULL
element	NULL
(	NULL
NRE	NULL
)	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
nuclear	NULL
extract	NULL
of	NULL
a	NULL
virus-infected	NULL
human	NULL
T	NULL
cell	NULL
line	NULL
.	NULL

One	NULL
of	NULL
the	NULL
factors	NULL
bound	NULL
to	NULL
a	NULL
novel	NULL
dyad	NULL
symmetrical	NULL
sequence	NULL
.	NULL

This	NULL
sequence	NULL
is	NULL
well	NULL
conserved	NULL
in	NULL
various	NULL
HIV-1	NULL
isolates	NULL
and	NULL
partial	NULL
homology	NULL
was	NULL
found	NULL
with	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
human	NULL
retinoblastoma	NULL
gene	NULL
.	NULL

Similar	NULL
DNA	NULL
binding	NULL
activity	NULL
was	NULL
detected	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
virus-uninfected	NULL
human	NULL
T	NULL
cell	NULL
lines	NULL
and	NULL
HeLa	NULL
cells	NULL
by	NULL
means	NULL
of	NULL
a	NULL
gel	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

The	NULL
other	NULL
factor	NULL
bound	NULL
to	NULL
a	NULL
putative	NULL
AP-1	NULL
recognition	NULL
sequence	NULL
predicted	NULL
for	NULL
the	NULL
HIV-1	NULL
NRE	NULL
.	NULL

However	NULL
,	NULL
this	NULL
factor	NULL
did	NULL
not	NULL
bind	NULL
to	NULL
a	NULL
typical	NULL
AP-1	NULL
site	NULL
.	NULL

The	NULL
insertion	NULL
of	NULL
multiple	NULL
copies	NULL
of	NULL
the	NULL
binding	NULL
site	NULL
for	NULL
the	NULL
former	NULL
or	NULL
latter	NULL
factor	NULL
into	NULL
a	NULL
heterologous	NULL
promoter	NULL
reduced	NULL
the	NULL
promoter	NULL
activity	NULL
to	NULL
one-tenth	NULL
or	NULL
one-third	NULL
,	NULL
respectively	NULL
.	NULL

Thus	NULL
,	NULL
each	NULL
factor	NULL
may	NULL
function	NULL
as	NULL
a	NULL
novel	NULL
negative	NULL
regulator	NULL
of	NULL
transcription	NULL
.	NULL

INTRODUCTION	NULL
Human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
,	NULL
an	NULL
etiologic	NULL
agent	NULL
of	NULL
acquired	NULL
immunodeficiency	NULL
syndrome	NULL
(	NULL
AIDS	NULL
)	NULL
(	NULL
1-3	NULL
)	NULL
,	NULL
is	NULL
a	NULL
highly	NULL
regulated	NULL
retrovirus	NULL
(	NULL
reviewed	NULL
in	NULL
refs	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

Previous	NULL
studies	NULL
demonstrated	NULL
the	NULL
location	NULL
of	NULL
cis-acting	NULL
regulatory	NULL
elements	NULL
within	NULL
the	NULL
HIV-1	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
.	NULL

The	NULL
trans-activation	NULL
responsive	NULL
(	NULL
TAR	NULL
)	NULL
element	NULL
,	NULL
which	NULL
is	NULL
located	NULL
between	NULL
-17	NULL
and	NULL
+80	NULL
(	NULL
+1	NULL
being	NULL
the	NULL
mRNA	NULL
capping	NULL
site	NULL
;	NULL
ref	NULL
.	NULL

6	NULL
)	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
indispensable	NULL
for	NULL
trans-activation	NULL
by	NULL
a	NULL
viral	NULL
protein	NULL
,	NULL
Tat	NULL
(	NULL
7-12	NULL
)	NULL
.	NULL

The	NULL
enhancer	NULL
region	NULL
(	NULL
-105	NULL
to	NULL
-80	NULL
;	NULL
refs	NULL
.	NULL

6	NULL
,	NULL
13	NULL
)	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
responsible	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
HIV-1	NULL
gene	NULL
expression	NULL
through	NULL
T	NULL
cell	NULL
activation	NULL
signals	NULL
(	NULL
13-17	NULL
)	NULL
.	NULL

The	NULL
negative	NULL
regulatory	NULL
element	NULL
(	NULL
NRE	NULL
)	NULL
was	NULL
found	NULL
far	NULL
upstream	NULL
from	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
and	NULL
is	NULL
mapped	NULL
over	NULL
hundreds	NULL
of	NULL
bases	NULL
(	NULL
6	NULL
,	NULL
18	NULL
)	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
NRE	NULL
resulted	NULL
in	NULL
increases	NULL
in	NULL
the	NULL
basal	NULL
level	NULL
and	NULL
Tat-induced	NULL
trans-activation	NULL
of	NULL
HIV-1	NULL
transcription	NULL
(	NULL
6	NULL
,	NULL
16	NULL
,	NULL
18	NULL
)	NULL
.	NULL

The	NULL
molecular	NULL
basis	NULL
of	NULL
the	NULL
function	NULL
of	NULL
each	NULL
element	NULL
has	NULL
been	NULL
characterized	NULL
through	NULL
analysis	NULL
of	NULL
the	NULL
sequence-specific	NULL
DNA	NULL
binding	NULL
proteins	NULL
that	NULL
interact	NULL
specifically	NULL
with	NULL
the	NULL
individual	NULL
elements	NULL
.	NULL

The	NULL
interaction	NULL
of	NULL
LBP-1/UBP-1	NULL
(	NULL
19-21	NULL
)	NULL
with	NULL
the	NULL
TAR	NULL
element	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
responsible	NULL
for	NULL
the	NULL
basal	NULL
and	NULL
Tat-induced	NULL
trans-activation	NULL
of	NULL
HIV-1	NULL
transcription	NULL
(	NULL
20	NULL
,	NULL
22	NULL
)	NULL
.	NULL

The	NULL
enhancer	NULL
binding	NULL
proteins	NULL
,	NULL
which	NULL
have	NULL
been	NULL
extensively	NULL
purified	NULL
by	NULL
several	NULL
groups	NULL
(	NULL
21	NULL
,	NULL
23	NULL
,	NULL
24	NULL
)	NULL
,	NULL
are	NULL
considered	NULL
to	NULL
transmit	NULL
extracellular	NULL
stimuli	NULL
and	NULL
to	NULL
trigger	NULL
HIV-1	NULL
transcription	NULL
(	NULL
25	NULL
)	NULL
.	NULL

The	NULL
NRE	NULL
also	NULL
has	NULL
a	NULL
number	NULL
of	NULL
potential	NULL
protein-binding	NULL
sites	NULL
.	NULL

The	NULL
sequence	NULL
between	NULL
-349	NULL
and	NULL
-330	NULL
contains	NULL
putative	NULL
recognition	NULL
sites	NULL
for	NULL
the	NULL
cellular	NULL
trans-activator	NULL
protein	NULL
,	NULL
AP-1	NULL
(	NULL
26	NULL
)	NULL
.	NULL

It	NULL
was	NULL
reported	NULL
,	NULL
however	NULL
,	NULL
that	NULL
this	NULL
region	NULL
was	NULL
bound	NULL
by	NULL
a	NULL
T	NULL
cell	NULL
protein	NULL
,	NULL
presumably	NULL
a	NULL
member	NULL
of	NULL
the	NULL
steroid/thyroid	NULL
hormone	NULL
receptor	NULL
super	NULL
family	NULL
,	NULL
not	NULL
by	NULL
AP-1	NULL
(	NULL
27	NULL
)	NULL
.	NULL

More	NULL
recently	NULL
,	NULL
human	NULL
counterparts	NULL
of	NULL
the	NULL
chicken	NULL
ovalbumin	NULL
upstream	NULL
promoter	NULL
transcription	NULL
factors	NULL
(	NULL
COUP-TFs	NULL
)	NULL
were	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
this	NULL
region	NULL
(	NULL
28	NULL
)	NULL
.	NULL

The	NULL
region	NULL
from	NULL
-254	NULL
to	NULL
-216	NULL
was	NULL
found	NULL
to	NULL
be	NULL
protected	NULL
from	NULL
DNase	NULL
I	NULL
digestion	NULL
by	NULL
the	NULL
nuclear	NULL
extract	NULL
of	NULL
an	NULL
activated	NULL
human	NULL
T	NULL
cell	NULL
line	NULL
,	NULL
Jurkat	NULL
(	NULL
29	NULL
)	NULL
.	NULL

A	NULL
DNA	NULL
fragment	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
containing	NULL
these	NULL
sequences	NULL
competed	NULL
with	NULL
the	NULL
canonical	NULL
binding	NULL
site	NULL
for	NULL
a	NULL
T	NULL
cell	NULL
activation-specific	NULL
transcription	NULL
factor	NULL
,	NULL
NFAT-1	NULL
(	NULL
29	NULL
)	NULL
.	NULL

The	NULL
sequence	NULL
between	NULL
-179	NULL
and	NULL
-159	NULL
was	NULL
also	NULL
protected	NULL
by	NULL
a	NULL
partially	NULL
purified	NULL
HeLa	NULL
cell	NULL
extract	NULL
(	NULL
19	NULL
)	NULL
.	NULL

This	NULL
sequence	NULL
is	NULL
remarkably	NULL
similar	NULL
to	NULL
that	NULL
recognized	NULL
by	NULL
the	NULL
upstream	NULL
stimulatory	NULL
factor	NULL
(	NULL
USF	NULL
;	NULL
ref	NULL
.	NULL

30	NULL
)	NULL
.	NULL

Very	NULL
recently	NULL
,	NULL
it	NULL
was	NULL
shown	NULL
that	NULL
a	NULL
mutant	NULL
HIV-1	NULL
provirus	NULL
,	NULL
of	NULL
which	NULL
the	NULL
NFAT-1	NULL
site	NULL
or	NULL
USF	NULL
site	NULL
within	NULL
the	NULL
NRE	NULL
was	NULL
selectively	NULL
deleted	NULL
,	NULL
replicated	NULL
more	NULL
rapidly	NULL
in	NULL
Jurkat	NULL
cells	NULL
than	NULL
the	NULL
wild	NULL
type	NULL
did	NULL
(	NULL
31	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
proteins	NULL
described	NULL
above	NULL
,	NULL
we	NULL
identified	NULL
a	NULL
new	NULL
member	NULL
of	NULL
the	NULL
HIV-1	NULL
NRE-binding	NULL
protein	NULL
in	NULL
a	NULL
partially	NULL
purified	NULL
T	NULL
cell	NULL
nuclear	NULL
extract	NULL
.	NULL

This	NULL
cellular	NULL
factor	NULL
,	NULL
designated	NULL
as	NULL
NRT-1	NULL
,	NULL
was	NULL
shown	NULL
to	NULL
suppress	NULL
the	NULL
transcription	NULL
from	NULL
a	NULL
heterologous	NULL
promoter	NULL
containing	NULL
multiple	NULL
copies	NULL
of	NULL
the	NULL
binding	NULL
site	NULL
for	NULL
this	NULL
factor	NULL
positioned	NULL
upstream	NULL
from	NULL
the	NULL
TATA	NULL
box	NULL
.	NULL

We	NULL
also	NULL
*	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
6108	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
Vol	NULL
.	NULL

19	NULL
,	NULL
No	NULL
.	NULL

22	NULL
identified	NULL
a	NULL
weak	NULL
transcriptional	NULL
suppressor	NULL
that	NULL
bound	NULL
to	NULL
the	NULL
putative	NULL
AP-1	NULL
site	NULL
within	NULL
the	NULL
HIV-1	NULL
NRE	NULL
and	NULL
present	NULL
evidence	NULL
that	NULL
this	NULL
factor	NULL
is	NULL
distinct	NULL
from	NULL
AP-1	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
culture	NULL
and	NULL
nuclear	NULL
extract	NULL
preparation	NULL
The	NULL
HIV-1-infected	NULL
human	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
,	NULL
H9/IIIB	NULL
,	NULL
which	NULL
were	NULL
maintained	NULL
in	NULL
RPMI1640	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
Drs	NULL
T.Hamakado	NULL
and	NULL
M.	NULL
Mizukoshi	NULL
(	NULL
FUJIREBIO	NULL
Inc.	NULL
,	NULL
Ube	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

H9	NULL
,	NULL
Jurkat	NULL
and	NULL
MOLT4	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
RPMI1640	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

HeLa	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
minimal	NULL
essential	NULL
medium	NULL
containing	NULL
5	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
(	NULL
32	NULL
)	NULL
,	NULL
and	NULL
then	NULL
dialyzed	NULL
against	NULL
buffer	NULL
PB-0.1	NULL
containing	NULL
50	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
100	NULL
mM	NULL
KCl	NULL
and	NULL
20	NULL
%	NULL
glycerol	NULL
.	NULL

The	NULL
handling	NULL
of	NULL
the	NULL
virus-infected	NULL
cells	NULL
and	NULL
preparation	NULL
of	NULL
the	NULL
nuclear	NULL
extract	NULL
were	NULL
carried	NULL
out	NULL
in	NULL
the	NULL
P3	NULL
facility	NULL
at	NULL
the	NULL
FUJIREBIO	NULL
Ube	NULL
Laboratory	NULL
.	NULL

Fractionation	NULL
of	NULL
the	NULL
nuclear	NULL
extract	NULL
The	NULL
H9/IIIB	NULL
nuclear	NULL
extract	NULL
(	NULL
approximately	NULL
100	NULL
mg	NULL
protein	NULL
)	NULL
was	NULL
applied	NULL
to	NULL
a	NULL
30	NULL
ml	NULL
heparin-Sepharose	NULL
(	NULL
Pharmacia	NULL
)	NULL
column	NULL
equilibrated	NULL
with	NULL
buffer	NULL
PB-0.1	NULL
.	NULL

The	NULL
column	NULL
was	NULL
washed	NULL
with	NULL
150	NULL
ml	NULL
of	NULL
buffer	NULL
PB-0.1	NULL
,	NULL
and	NULL
then	NULL
the	NULL
bound	NULL
proteins	NULL
were	NULL
fractionated	NULL
by	NULL
step-wise	NULL
elution	NULL
.	NULL

The	NULL
0.4	NULL
M	NULL
KCI	NULL
fraction	NULL
was	NULL
diluted	NULL
with	NULL
buffer	NULL
PB-0.0	NULL
(	NULL
no	NULL
KCI	NULL
)	NULL
to	NULL
0.1	NULL
M	NULL
KCl	NULL
and	NULL
subsequently	NULL
loaded	NULL
onto	NULL
a	NULL
10	NULL
ml	NULL
DEAE-Sepharose	NULL
(	NULL
Pharmacia	NULL
)	NULL
column	NULL
equilibrated	NULL
with	NULL
buffer	NULL
PB-0.1	NULL
.	NULL

The	NULL
column	NULL
was	NULL
washed	NULL
with	NULL
30	NULL
ml	NULL
of	NULL
PB-0.1	NULL
and	NULL
then	NULL
the	NULL
bound	NULL
proteins	NULL
were	NULL
recovered	NULL
by	NULL
step-wise	NULL
elution	NULL
with	NULL
buffer	NULL
PB-0.2	NULL
and	NULL
PB-0.4	NULL
,	NULL
containing	NULL
0.2	NULL
M	NULL
and	NULL
0.4	NULL
M	NULL
KCI	NULL
,	NULL
respectively	NULL
.	NULL

Each	NULL
fraction	NULL
was	NULL
precipitated	NULL
by	NULL
60-70	NULL
%	NULL
saturation	NULL
with	NULL
ammonium	NULL
sulfate	NULL
.	NULL

The	NULL
pellets	NULL
were	NULL
suspended	NULL
and	NULL
dialyzed	NULL
against	NULL
buffer	NULL
PB-0.1	NULL
,	NULL
and	NULL
then	NULL
stored	NULL
in	NULL
aliquots	NULL
at	NULL
-80°C	NULL
.	NULL

Plasmid	NULL
construction	NULL
and	NULL
DNA	NULL
probes	NULL
A	NULL
718-base-pair	NULL
(	NULL
bp	NULL
)	NULL
Dral	NULL
fragment	NULL
containing	NULL
the	NULL
entire	NULL
U3	NULL
and	NULL
R	NULL
regions	NULL
of	NULL
HIV-1	NULL
was	NULL
excised	NULL
from	NULL
a	NULL
plasmid	NULL
,	NULL
pCD12	NULL
(	NULL
33	NULL
)	NULL
,	NULL
and	NULL
then	NULL
sub-cloned	NULL
into	NULL
the	NULL
Smal	NULL
site	NULL
of	NULL
another	NULL
plasmid	NULL
,	NULL
pTZI18R	NULL
(	NULL
United	NULL
States	NULL
Biochemical	NULL
Corp.	NULL
)	NULL
.	NULL

This	NULL
construct	NULL
,	NULL
pTHL8RSS	NULL
,	NULL
was	NULL
3'-end-labeled	NULL
at	NULL
the	NULL
EcoRI	NULL
site	NULL
with	NULL
[	NULL
a	NULL
«	NULL
-P	NULL
]	NULL
dATP	NULL
and	NULL
the	NULL
Klenow	NULL
enzyme	NULL
,	NULL
followed	NULL
by	NULL
cleavage	NULL
at	NULL
the	NULL
Hincl	NULL
!	NULL

site	NULL
.	NULL

The	NULL
labeled	NULL
fragments	NULL
were	NULL
isolated	NULL
by	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
as	NULL
described	NULL
(	NULL
34	NULL
)	NULL
and	NULL
used	NULL
as	NULL
probes	NULL
for	NULL
DNase	NULL
I	NULL
footprint	NULL
experiments	NULL
.	NULL

To	NULL
obtain	NULL
a	NULL
smaller	NULL
DNA	NULL
fragment	NULL
suitable	NULL
for	NULL
the	NULL
methylation	NULL
interference	NULL
experiment	NULL
,	NULL
plasmid	NULL
pTHL8RSS	NULL
was	NULL
digested	NULL
with	NULL
Dralll	NULL
and	NULL
BsfYI	NULL
,	NULL
and	NULL
then	NULL
blunt-ended	NULL
with	NULL
T4	NULL
DNA	NULL
polymerase	NULL
.	NULL

One	NULL
of	NULL
the	NULL
resultant	NULL
DNA	NULL
fragments	NULL
containing	NULL
the	NULL
region	NULL
from	NULL
-404	NULL
to	NULL
-245	NULL
of	NULL
HIV-1	NULL
NRE	NULL
was	NULL
purified	NULL
and	NULL
then	NULL
cloned	NULL
into	NULL
the	NULL
Smal	NULL
site	NULL
of	NULL
pTZ18R	NULL
.	NULL

Probe	NULL
preparation	NULL
from	NULL
the	NULL
resultant	NULL
constructs	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
above	NULL
,	NULL
followed	NULL
by	NULL
partial	NULL
methylation	NULL
with	NULL
dimethyl	NULL
sulfoxide	NULL
as	NULL
described	NULL
(	NULL
34	NULL
)	NULL
.	NULL

For	NULL
gel	NULL
mobility	NULL
shift	NULL
assays	NULL
,	NULL
double-stranded	NULL
oligonucleotides	NULL
complementary	NULL
to	NULL
the	NULL
sequences	NULL
protected	NULL
from	NULL
DNase	NULL
I	NULL
digestion	NULL
were	NULL
chemically	NULL
synthesized	NULL
(	NULL
the	NULL
sequences	NULL
are	NULL
listed	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
with	NULL
a	NULL
DNA	NULL
synthesizer	NULL
(	NULL
Applied	NULL
Biosystem	NULL
model	NULL
380B	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
oligonucleotides	NULL
containing	NULL
3	NULL
base-substitutions	NULL
in	NULL
half	NULL
of	NULL
the	NULL
symmetrical	NULL
sequence	NULL
of	NULL
probe	NULL
A	NULL
and	NULL
2	NULL
base-substitutions	NULL
in	NULL
the	NULL
sequence	NULL
of	NULL
probe	NULL
B	NULL
were	NULL
also	NULL
synthesized	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

These	NULL
oligonucleotides	NULL
were	NULL
5'-end-labeled	NULL
with	NULL
[	NULL
y-	NULL
>	NULL
P	NULL
]	NULL
ATP	NULL
and	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
,	NULL
annealed	NULL
and	NULL
then	NULL
electrophoretically	NULL
purified	NULL
.	NULL

For	NULL
the	NULL
insertion	NULL
of	NULL
multiple	NULL
copies	NULL
of	NULL
a	NULL
binding	NULL
site	NULL
,	NULL
we	NULL
designed	NULL
the	NULL
synthetic	NULL
oligonucleotides	NULL
so	NULL
as	NULL
to	NULL
be	NULL
connected	NULL
in	NULL
one	NULL
direction	NULL
.	NULL

The	NULL
complementary	NULL
DNAs	NULL
for	NULL
site	NULL
1	NULL
CAAGCTAGTACCA-3	NULL
``	NULL
)	NULL
and	NULL
site	NULL
2	NULL
(	NULL
5'-TATCCACTGACC-TTT-3	NULL
'	NULL
)	NULL
,	NULL
with	NULL
three	NULL
guanine	NULL
and	NULL
cytosine	NULL
residues	NULL
at	NULL
the	NULL
5'-end	NULL
of	NULL
the	NULL
upper	NULL
and	NULL
lower	NULL
strands	NULL
,	NULL
respectively	NULL
,	NULL
were	NULL
chemically	NULL
synthesized	NULL
.	NULL

These	NULL
oligonucleotides	NULL
were	NULL
5'-phosphorylated	NULL
with	NULL
ATP	NULL
and	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
,	NULL
annealed	NULL
and	NULL
then	NULL
polymerized	NULL
with	NULL
T4	NULL
DNA	NULL
ligase	NULL
.	NULL

The	NULL
polymerized	NULL
DNA	NULL
containing	NULL
four	NULL
copies	NULL
of	NULL
each	NULL
site	NULL
was	NULL
excised	NULL
from	NULL
a	NULL
polyacrylamide	NULL
gel	NULL
and	NULL
then	NULL
cloned	NULL
into	NULL
the	NULL
unique	NULL
Smal	NULL
site	NULL
of	NULL
a	NULL
plasmid	NULL
,	NULL
pRAU3-CAT	NULL
(	NULL
35	NULL
)	NULL
.	NULL

The	NULL
direction	NULL
of	NULL
the	NULL
inserted	NULL
fragment	NULL
was	NULL
determined	NULL
by	NULL
Smal	NULL
digestion	NULL
of	NULL
the	NULL
resultant	NULL
plasmid	NULL
.	NULL

DNA	NULL
binding	NULL
experiments	NULL
Binding	NULL
reactions	NULL
were	NULL
carried	NULL
out	NULL
in	NULL
20	NULL
gl	NULL
for	NULL
DNase	NULL
I	NULL
footprint	NULL
analysis	NULL
or	NULL
in	NULL
10	NULL
gl	NULL
for	NULL
the	NULL
gel	NULL
mobility	NULL
shift	NULL
assay	NULL
,	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
unlabeled	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
and	NULL
various	NULL
amounts	NULL
of	NULL
the	NULL
protein	NULL
fraction	NULL
,	NULL
under	NULL
final	NULL
buffer	NULL
conditions	NULL
of	NULL
25	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
50	NULL
mM	NULL
KCI	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
and	NULL
10	NULL
%	NULL
glycerol	NULL
.	NULL

Each	NULL
mixture	NULL
was	NULL
preincubated	NULL
for	NULL
10	NULL
min	NULL
on	NULL
ice	NULL
,	NULL
followed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
1-5	NULL
ng	NULL
of	NULL
the	NULL
end-labeled	NULL
DNA	NULL
probe	NULL
(	NULL
5,000-10,000	NULL
cpm	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
reactions	NULL
were	NULL
performed	NULL
for	NULL
20	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

For	NULL
DNase	NULL
I	NULL
footprint	NULL
analysis	NULL
,	NULL
the	NULL
binding	NULL
reaction	NULL
mixtures	NULL
were	NULL
digested	NULL
for	NULL
1	NULL
min	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
5	NULL
ul	NULL
of	NULL
a	NULL
DNase	NULL
I	NULL
digestion	NULL
mixture	NULL
(	NULL
5	NULL
mM	NULL
CaCl	NULL
,	NULL
,	NULL
10	NULL
mM	NULL
MgCl	NULL
;	NULL
and	NULL
0.2-0.5	NULL
units	NULL
of	NULL
RQ1	NULL
DNase	NULL
purchased	NULL
from	NULL
Promega	NULL
Inc.	NULL
,	NULL
with	NULL
the	NULL
same	NULL
buffer	NULL
conditions	NULL
as	NULL
for	NULL
the	NULL
binding	NULL
reactions	NULL
)	NULL
.	NULL

The	NULL
digestion	NULL
was	NULL
terminated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
60	NULL
ul	NULL
of	NULL
a	NULL
STOP	NULL
solution	NULL
(	NULL
50	NULL
mM	NULL
EDTA	NULL
,	NULL
0.2	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
and	NULL
100	NULL
ug/ml	NULL
tRNA	NULL
)	NULL
,	NULL
followed	NULL
by	NULL
extraction	NULL
with	NULL
phenol	NULL
and	NULL
chloroform	NULL
,	NULL
and	NULL
then	NULL
precipitation	NULL
twice	NULL
with	NULL
ethanol	NULL
.	NULL

The	NULL
pellets	NULL
were	NULL
rinsed	NULL
with	NULL
70	NULL
%	NULL
ethanol	NULL
and	NULL
then	NULL
dried	NULL
before	NULL
loading	NULL
on	NULL
a	NULL
10	NULL
%	NULL
sequencing	NULL
gel	NULL
.	NULL

For	NULL
the	NULL
gel	NULL
mobility	NULL
shift	NULL
assay	NULL
,	NULL
the	NULL
binding	NULL
reactions	NULL
were	NULL
mixed	NULL
with	NULL
4	NULL
gl	NULL
of	NULL
a	NULL
loading	NULL
buffer	NULL
(	NULL
0.05	NULL
%	NULL
bromophenol	NULL
blue	NULL
and	NULL
0.05	NULL
%	NULL
xylene	NULL
cyanol	NULL
,	NULL
with	NULL
the	NULL
same	NULL
buffer	NULL
conditions	NULL
as	NULL
for	NULL
the	NULL
reactions	NULL
)	NULL
and	NULL
then	NULL
electrophoresed	NULL
on	NULL
a	NULL
6	NULL
%	NULL
non-denaturing	NULL
polyacrylamide	NULL
gel	NULL
at	NULL
5°C	NULL
.	NULL

For	NULL
the	NULL
methylation	NULL
interference	NULL
assay	NULL
,	NULL
the	NULL
binding	NULL
reactions	NULL
with	NULL
the	NULL
partially	NULL
methylated	NULL
DNA	NULL
probes	NULL
were	NULL
scaled	NULL
up	NULL
to	NULL
10-fold	NULL
.	NULL

Free	NULL
and	NULL
bound	NULL
DNAs	NULL
were	NULL
separated	NULL
as	NULL
described	NULL
above	NULL
and	NULL
then	NULL
purified	NULL
with	NULL
QIAGEN	NULL
(	NULL
DIAGEN	NULL
)	NULL
.	NULL

The	NULL
DNAs	NULL
were	NULL
cleaved	NULL
as	NULL
described	NULL
(	NULL
34	NULL
)	NULL
and	NULL
then	NULL
applied	NULL
on	NULL
a	NULL
8	NULL
%	NULL
sequencing	NULL
gel	NULL
.	NULL

Transfection	NULL
and	NULL
CAT	NULL
assay	NULL
The	NULL
plasmids	NULL
used	NULL
for	NULL
transfection	NULL
were	NULL
quantitated	NULL
by	NULL
measurement	NULL
of	NULL
the	NULL
optical	NULL
density	NULL
at	NULL
280	NULL
nm	NULL
and	NULL
then	NULL
on	NULL
an	NULL
ethidium	NULL
bromide-stained	NULL
agarose	NULL
gel	NULL
.	NULL

2	NULL
x	NULL
106	NULL
Jurkat	NULL
cells	NULL
were	NULL
co-transfected	NULL
with	NULL
4	NULL
ug	NULL
of	NULL
each	NULL
CAT	NULL
construct	NULL
described	NULL
above	NULL
and	NULL
4	NULL
4g	NULL
of	NULL
a	NULL
control	NULL
plasmid	NULL
carrying	NULL
the	NULL
B-galactosidase	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
G-actin	NULL
promoter	NULL
by	NULL
means	NULL
of	NULL
electroporation	NULL
(	NULL
36	NULL
)	NULL
.	NULL

The	NULL
transfected	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
48	NULL
hours	NULL
in	NULL
RPMI1640	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
and	NULL
then	NULL
harvested	NULL
for	NULL
CAT	NULL
assays	NULL
.	NULL

The	NULL
CAT	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
3	NULL
ug	NULL
of	NULL
a	NULL
cell	NULL
lysate	NULL
under	NULL
the	NULL
standard	NULL
conditions	NULL
(	NULL
36	NULL
,	NULL
37	NULL
)	NULL
.	NULL

Transfection	NULL
efficiency	NULL
was	NULL
determined	NULL
by	NULL
measurement	NULL
of	NULL
B-galactosidase	NULL
activity	NULL
in	NULL
the	NULL
lysate	NULL
.	NULL

The	NULL
conversion	NULL
of	NULL
chloramphenicol	NULL
in	NULL
each	NULL
assay	NULL
was	NULL
determined	NULL
by	NULL
densitometric	NULL
scanning	NULL
of	NULL
the	NULL
autoradiograph	NULL
.	NULL

Values	NULL
were	NULL
normalized	NULL
to	NULL
the	NULL
transfection	NULL
efficiency	NULL
.	NULL

RESULTS	NULL
Identification	NULL
of	NULL
HIV-1	NULL
NRE-binding	NULL
proteins	NULL
in	NULL
the	NULL
nuclear	NULL
extract	NULL
of	NULL
a	NULL
HIV-1	NULL
infected	NULL
human	NULL
T	NULL
lymphocyte	NULL
cell	NULL
line	NULL
We	NULL
prepared	NULL
a	NULL
nuclear	NULL
extract	NULL
from	NULL
a	NULL
HIV-1l-infected	NULL
human	NULL
CD4+	NULL
T	NULL
cell	NULL
line	NULL
,	NULL
H9/IIIB	NULL
,	NULL
and	NULL
fractionated	NULL
it	NULL
on	NULL
a	NULL
heparin-Sepharose	NULL
column	NULL
.	NULL

The	NULL
0.4	NULL
M	NULL
KCl	NULL
fraction	NULL
from	NULL
the	NULL
column	NULL
,	NULL
in	NULL
which	NULL
the	NULL
majority	NULL
of	NULL
the	NULL
stimulatory	NULL
activity	NULL
for	NULL
HIV-1	NULL
LTR-specific	NULL
transcription	NULL
was	NULL
present	NULL
(	NULL
33	NULL
)	NULL
,	NULL
was	NULL
further	NULL
fractionated	NULL
by	NULL
step-wise	NULL
elution	NULL
from	NULL
a	NULL
DEAE-Sepharose	NULL
column	NULL
.	NULL

The	NULL
resulting	NULL
eluates	NULL
were	NULL
used	NULL
for	NULL
a	NULL
DNase	NULL
I	NULL
footprint	NULL
experiment	NULL
.	NULL

Fr4.1	NULL
(	NULL
the	NULL
flow-through	NULL
fraction	NULL
from	NULL
the	NULL
DEAE-Sepharose	NULL
column	NULL
)	NULL
protected	NULL
the	NULL
region	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
between	NULL
-338	NULL
and	NULL
-325	NULL
upstream	NULL
from	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

This	NULL
region	NULL
contains	NULL
one	NULL
of	NULL
two	NULL
putative	NULL
recognition	NULL
sites	NULL
for	NULL
a	NULL
cellular	NULL
transcription	NULL
factor	NULL
,	NULL
AP-1	NULL
(	NULL
26	NULL
;	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Another	NULL
fraction	NULL
,	NULL
Fr4.2	NULL
(	NULL
the	NULL
0.2	NULL
M	NULL
fraction	NULL
from	NULL
the	NULL
DEAE-Sepharose	NULL
column	NULL
)	NULL
,	NULL
contained	NULL
a	NULL
novel	NULL
factor	NULL
which	NULL
bound	NULL
to	NULL
a	NULL
region	NULL
adjacent	NULL
to	NULL
the	NULL
region	NULL
protected	NULL
by	NULL
Fr4.1	NULL
(	NULL
-320	NULL
to	NULL
-295	NULL
;	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

This	NULL
newly	NULL
identified	NULL
region	NULL
contains	NULL
a	NULL
pseudo-dyad	NULL
symmetrical	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

To	NULL
precisely	NULL
localize	NULL
the	NULL
sequence	NULL
recognized	NULL
by	NULL
this	NULL
factor	NULL
,	NULL
a	NULL
DNase	NULL
I	NULL
footprint	NULL
experiment	NULL
on	NULL
the	NULL
other	NULL
strand	NULL
and	NULL
a	NULL
methylation	NULL
interference	NULL
experiment	NULL
on	NULL
both	NULL
strands	NULL
were	NULL
performed	NULL
for	NULL
Fr4.2	NULL
.	NULL

The	NULL
results	NULL
are	NULL
summarized	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Some	NULL
other	NULL
regions	NULL
downstream	NULL
from	NULL
those	NULL
indicated	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
were	NULL
also	NULL
protected	NULL
,	NULL
such	NULL
as	NULL
the	NULL
enhancer	NULL
region	NULL
by	NULL
Fr4.1	NULL
Fr4.2	NULL
0	NULL
5	NULL
10	NULL
0	NULL
5	NULL
10	NULL
0	NULL
Figure	NULL
1	NULL
.	NULL

HIV-1	NULL
NRE	NULL
binding	NULL
activity	NULL
in	NULL
fractions	NULL
of	NULL
HIV-1-infected	NULL
H9	NULL
cells	NULL
.	NULL

The	NULL
DNase	NULL
I	NULL
protection	NULL
patterns	NULL
for	NULL
the	NULL
non-coding	NULL
strand	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
with	NULL
no	NULL
protein	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
4	NULL
and	NULL
7	NULL
)	NULL
,	NULL
and	NULL
5	NULL
l	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
5	NULL
)	NULL
and	NULL
10	NULL
pl	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
6	NULL
)	NULL
of	NULL
partially	NULL
purified	NULL
protein	NULL
fractions	NULL
of	NULL
a	NULL
HIV-l-infected	NULL
H9	NULL
nuclear	NULL
extract	NULL
(	NULL
designated	NULL
as	NULL
Fr4.1	NULL
or	NULL
Fr4.2	NULL
;	NULL
see	NULL
Materials	NULL
and	NULL
methods	NULL
)	NULL
are	NULL
shown	NULL
.	NULL

G	NULL
and	NULL
AG	NULL
are	NULL
Maxam-Gilbert	NULL
sequence	NULL
ladders	NULL
.	NULL

The	NULL
regions	NULL
protected	NULL
from	NULL
DNase	NULL
I	NULL
digestion	NULL
are	NULL
also	NULL
indicated	NULL
,	NULL
as	NULL
boxes	NULL
with	NULL
the	NULL
corresponding	NULL
nucleotide	NULL
numbers	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
Vol	NULL
.	NULL

19	NULL
,	NULL
No	NULL
.	NULL

22	NULL
6109	NULL
Fr4.1	NULL
and	NULL
the	NULL
TAR	NULL
region	NULL
by	NULL
Fr4.2	NULL
,	NULL
respectively	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
confirm	NULL
the	NULL
sequence-specificity	NULL
of	NULL
each	NULL
factor	NULL
,	NULL
we	NULL
performed	NULL
gel	NULL
mobility	NULL
shift	NULL
assays	NULL
with	NULL
synthetic	NULL
oligonucleotide	NULL
probes	NULL
containing	NULL
the	NULL
protected	NULL
sequence	NULL
in	NULL
the	NULL
DNase	NULL
I	NULL
footprint	NULL
experiment	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

A	NULL
specific	NULL
protein-DNA	NULL
complex	NULL
was	NULL
detected	NULL
when	NULL
the	NULL
protein	NULL
fraction	NULL
was	NULL
incubated	NULL
with	NULL
the	NULL
corresponding	NULL
radio-labeled	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

A	NULL
10-	NULL
or	NULL
50-fold	NULL
molar-excess	NULL
of	NULL
the	NULL
unlabeled	NULL
oligonucleotides	NULL
efficiently	NULL
competed	NULL
with	NULL
the	NULL
probe	NULL
,	NULL
while	NULL
the	NULL
same	NULL
amount	NULL
of	NULL
base-substituted	NULL
mutant	NULL
oligonucleotides	NULL
(	NULL
the	NULL
sequences	NULL
listed	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
did	NULL
not	NULL
.	NULL

Moreover	NULL
,	NULL
a	NULL
similar	NULL
type	NULL
of	NULL
competition	NULL
experiment	NULL
involving	NULL
DNase	NULL
I	NULL
footprint	NULL
assays	NULL
gave	NULL
a	NULL
consistent	NULL
result	NULL
,	NULL
that	NULL
is	NULL
,	NULL
the	NULL
footprint	NULL
of	NULL
the	NULL
-320	NULL
to	NULL
-295	NULL
region	NULL
was	NULL
effectively	NULL
abolished	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
wild	NULL
type	NULL
oligonucleotides	NULL
,	NULL
but	NULL
not	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
mutant	NULL
ones	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
the	NULL
highly	NULL
sequence-specific	NULL
interaction	NULL
of	NULL
these	NULL
NRE-binding	NULL
proteins	NULL
with	NULL
DNA	NULL
.	NULL

«	NULL
seo	NULL
se	NULL
wo	NULL
«	NULL
wo	NULL
*	NULL
s10	NULL
°	NULL
O	NULL
ao	NULL
1	NULL
AGGAGTCAGATATCCACTGAECWGGATGWGCTACMGCTAMACCAWGAGCCAGATMGATA	NULL
TCCTCAGTCTATAGGTGACTGGAAACCTACCACGATGTTCGATCATGGTCAACTCGGTCTATTCTAT	NULL
|	NULL
J	NULL
§	NULL
®	NULL
9	NULL
s	NULL
4	NULL
site	NULL
2	NULL
site	NULL
1	NULL
pote	NULL
A.	NULL
GGATGGTGCTACAAGCTAGTACCAGTTGAGCCAG	NULL
me	NULL
t	NULL
GCA	NULL
Tec	NULL
prote	NULL
8	NULL
:	NULL
GGTCAGATATCCACTGACCTTTGG	NULL
m	NULL
2	NULL
:	NULL
or	NULL
Figure	NULL
2	NULL
.	NULL

A	NULL
portion	NULL
of	NULL
the	NULL
NRE	NULL
sequence	NULL
in	NULL
the	NULL
HIV-1	NULL
LTR	NULL
.	NULL

The	NULL
brackets	NULL
indicate	NULL
regions	NULL
protected	NULL
from	NULL
DNase	NULL
I	NULL
digestion	NULL
.	NULL

The	NULL
dashed	NULL
lines	NULL
indicate	NULL
regions	NULL
of	NULL
weak	NULL
protection	NULL
.	NULL

The	NULL
arrows	NULL
between	NULL
the	NULL
sequences	NULL
indicate	NULL
the	NULL
pseudo-dyad	NULL
symmetry	NULL
found	NULL
in	NULL
site	NULL
1	NULL
.	NULL

The	NULL
dashed	NULL
lines	NULL
between	NULL
the	NULL
sequences	NULL
are	NULL
putative	NULL
AP-1	NULL
recognition	NULL
sites	NULL
.	NULL

The	NULL
asterisks	NULL
and	NULL
open	NULL
circles	NULL
represent	NULL
points	NULL
of	NULL
strong	NULL
and	NULL
weak	NULL
methylation	NULL
interference	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
the	NULL
probes	NULL
and	NULL
the	NULL
base-substituted	NULL
oligonucleotides	NULL
used	NULL
in	NULL
the	NULL
gel	NULL
mobility	NULL
shift	NULL
assays	NULL
are	NULL
also	NULL
indicated	NULL
.	NULL

Fr4.2/probe	NULL
A	NULL
Fr4.1/probe	NULL
8	NULL
2	NULL
1	NULL
competitor	NULL
wt	NULL
mt	NULL
1	NULL
wt	NULL
mt	NULL
2	NULL
~23	NULL
C-	NULL
|	NULL
poo	NULL
1	NULL
10	NULL
50	NULL
10	NULL
50	NULL
>	NULL
tuhis	NULL
.	NULL

dubbed	NULL
10	NULL
50	NULL
10	NULL
50	NULL
Wis	NULL
WH	NULL
Figure	NULL
3	NULL
.	NULL

Gel	NULL
mobility	NULL
shift	NULL
assays	NULL
with	NULL
the	NULL
NRE-binding	NULL
factors	NULL
.	NULL

2	NULL
gl	NULL
aliquots	NULL
of	NULL
Fr4.2	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
5	NULL
)	NULL
and	NULL
Fr4.1	NULL
(	NULL
lanes	NULL
6	NULL
to	NULL
10	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
corresponding	NULL
probes	NULL
.	NULL

The	NULL
results	NULL
of	NULL
competition	NULL
experiments	NULL
with	NULL
the	NULL
indicated	NULL
molar-excess	NULL
amounts	NULL
of	NULL
non-radiolabeled	NULL
wild	NULL
type	NULL
or	NULL
mutant	NULL
oligonucleotides	NULL
are	NULL
shown	NULL
.	NULL

6110	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
Vol	NULL
.	NULL

19	NULL
,	NULL
No	NULL
.	NULL

22	NULL
#	NULL
u	NULL
“	NULL
a	NULL
@	NULL
n	NULL
bood	NULL
lund	NULL
is	NULL
prc	NULL
@	NULL
-	NULL
!	NULL

¥	NULL
Figure	NULL
4	NULL
.	NULL

Detection	NULL
of	NULL
the	NULL
interaction	NULL
of	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
in	NULL
various	NULL
cell	NULL
lines	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
(	NULL
A	NULL
)	NULL
probe	NULL
A	NULL
or	NULL
(	NULL
B	NULL
)	NULL
probe	NULL
B	NULL
indicated	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
respectively	NULL
.	NULL

2	NULL
ug	NULL
of	NULL
Fr4.2	NULL
(	NULL
lane	NULL
1	NULL
in	NULL
A	NULL
)	NULL
or	NULL
Fr4.1	NULL
(	NULL
lane	NULL
1	NULL
in	NULL
B	NULL
)	NULL
,	NULL
and	NULL
10	NULL
ug	NULL
aliquots	NULL
of	NULL
nuclear	NULL
extracts	NULL
of	NULL
HIV-l-infected	NULL
H9	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
,	NULL
uninfected	NULL
H9	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
,	NULL
Jurkat	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
,	NULL
MOLT4	NULL
(	NULL
lanes	NULL
9	NULL
and	NULL
10	NULL
)	NULL
and	NULL
HeLa	NULL
(	NULL
lanes	NULL
11	NULL
and	NULL
12	NULL
)	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
4	NULL
,	NULL
6	NULL
,	NULL
8	NULL
,	NULL
10	NULL
and	NULL
12	NULL
)	NULL
or	NULL
without	NULL
the	NULL
wild	NULL
type	NULL
competitor	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
3	NULL
,	NULL
5	NULL
,	NULL
7	NULL
,	NULL
9	NULL
and	NULL
11	NULL
)	NULL
.	NULL

Distribution	NULL
of	NULL
the	NULL
HIV-1	NULL
NRE-binding	NULL
factors	NULL
in	NULL
various	NULL
cell	NULL
lines	NULL
We	NULL
next	NULL
,	NULL
examined	NULL
the	NULL
nuclear	NULL
extracts	NULL
of	NULL
various	NULL
HIV-	NULL
!	NULL

-uninfected	NULL
cell	NULL
lines	NULL
,	NULL
by	NULL
means	NULL
of	NULL
gel	NULL
mobility	NULL
shift	NULL
assays	NULL
,	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
HIV-1	NULL
NRE-binding	NULL
factors	NULL
are	NULL
viral	NULL
or	NULL
cellular	NULL
proteins	NULL
,	NULL
which	NULL
are	NULL
constitutively	NULL
expressed	NULL
or	NULL
induced	NULL
by	NULL
viral	NULL
infection	NULL
.	NULL

A	NULL
protein-DNA	NULL
complex	NULL
with	NULL
the	NULL
same	NULL
mobility	NULL
as	NULL
that	NULL
of	NULL
Fr4.2	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
HIV-1	NULL
-uninfected	NULL
H9	NULL
,	NULL
Jurkat	NULL
,	NULL
MOLT4	NULL
and	NULL
HeLa	NULL
cells	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
specificity	NULL
of	NULL
each	NULL
complex	NULL
was	NULL
confirmed	NULL
by	NULL
the	NULL
competition	NULL
with	NULL
a	NULL
10-fold	NULL
molar-excess	NULL
of	NULL
unlabeled	NULL
oligonucleotides	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
this	NULL
factor	NULL
in	NULL
HIV-1-infected	NULL
or	NULL
uninfected	NULL
H9	NULL
cells	NULL
seems	NULL
to	NULL
be	NULL
greater	NULL
than	NULL
that	NULL
in	NULL
Jurkat	NULL
,	NULL
MOLT4	NULL
or	NULL
HeLa	NULL
cells	NULL
(	NULL
compare	NULL
lanes	NULL
3	NULL
and	NULL
5	NULL
with	NULL
lanes	NULL
7	NULL
,	NULL
9	NULL
and	NULL
11	NULL
)	NULL
.	NULL

Fig	NULL
.	NULL

4B	NULL
shows	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
factor	NULL
detected	NULL
in	NULL
Fr4.1	NULL
in	NULL
various	NULL
T	NULL
cell	NULL
lines	NULL
.	NULL

In	NULL
HeLa	NULL
cells	NULL
,	NULL
there	NULL
was	NULL
no	NULL
detectable	NULL
band	NULL
corresponding	NULL
to	NULL
that	NULL
observed	NULL
for	NULL
Fr4.1	NULL
,	NULL
whereas	NULL
a	NULL
thick	NULL
band	NULL
migrating	NULL
more	NULL
rapidly	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
gel	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lane	NULL
11	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
a	NULL
related	NULL
but	NULL
different	NULL
molecule	NULL
which	NULL
recognizes	NULL
the	NULL
same	NULL
DNA	NULL
sequence	NULL
is	NULL
expressed	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
or	NULL
that	NULL
the	NULL
same	NULL
protein	NULL
is	NULL
modified	NULL
in	NULL
different	NULL
ways	NULL
in	NULL
different	NULL
tissues	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

From	NULL
these	NULL
observations	NULL
,	NULL
we	NULL
concluded	NULL
that	NULL
the	NULL
factors	NULL
detected	NULL
in	NULL
the	NULL
nuclear	NULL
extract	NULL
fractions	NULL
were	NULL
cellular	NULL
proteins	NULL
which	NULL
are	NULL
constitutively	NULL
expressed	NULL
in	NULL
the	NULL
many	NULL
cell	NULL
lines	NULL
examined	NULL
here	NULL
.	NULL

A	NULL
factor	NULL
distinct	NULL
from	NULL
AP-1	NULL
binds	NULL
to	NULL
a	NULL
putative	NULL
AP-1	NULL
site	NULL
in	NULL
the	NULL
HIV-1	NULL
NRE	NULL
The	NULL
factor	NULL
detected	NULL
in	NULL
Fr4.1	NULL
bound	NULL
to	NULL
a	NULL
region	NULL
containing	NULL
a	NULL
putative	NULL
AP-1	NULL
binding	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
;	NULL
ref	NULL
.	NULL

26	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
this	NULL
factor	NULL
is	NULL
identical	NULL
or	NULL
related	NULL
to	NULL
AP-1	NULL
,	NULL
a	NULL
collagenase	NULL
gene	NULL
enhancer	NULL
which	NULL
contains	NULL
a	NULL
typical	NULL
AP-1	NULL
site	NULL
(	NULL
38	NULL
)	NULL
was	NULL
analyzed	NULL
as	NULL
to	NULL
its	NULL
binding	NULL
to	NULL
the	NULL
factor	NULL
in	NULL
Fr4.1	NULL
.	NULL

When	NULL
the	NULL
AP-1	NULL
like	NULL
sequence	NULL
in	NULL
the	NULL
HIV-1	NULL
NRE	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
,	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
specific	NULL
protein-DNA	NULL
complex	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
either	NULL
wild	NULL
type	NULL
or	NULL
mutant	NULL
oligonucleotides	NULL
of	NULL
the	NULL
AP-1	NULL
site	NULL
from	NULL
the	NULL
collagenase	NULL
gene	NULL
enhancer	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Similar	NULL
DNA	NULL
binding	NULL
specificity	NULL
was	NULL
demonstrated	NULL
with	NULL
the	NULL
factor	NULL
detected	NULL
in	NULL
HeLa	NULL
cell	NULL
nuclei	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
factor	NULL
that	NULL
bound	NULL
to	NULL
this	NULL
HIV-1	NULL
sequence	NULL
has	NULL
a	NULL
DNA	NULL
binding	NULL
specificity	NULL
distinct	NULL
from	NULL
that	NULL
of	NULL
AP-1	NULL
.	NULL

Conversely	NULL
,	NULL
when	NULL
the	NULL
AP-1	NULL
site	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
,	NULL
no	NULL
retarded	NULL
band	NULL
was	NULL
observed	NULL
for	NULL
Fr4.1	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
the	NULL
factor	NULL
in	NULL
Fr4.1	NULL
is	NULL
a	NULL
DNA	NULL
binding	NULL
protein	NULL
distinct	NULL
from	NULL
AP-1	NULL
.	NULL

Multiple	NULL
copies	NULL
of	NULL
the	NULL
NRE-binding	NULL
factor	NULL
recognition	NULL
sequence	NULL
suppress	NULL
the	NULL
transcription	NULL
from	NULL
a	NULL
heterologous	NULL
promoter	NULL
To	NULL
examine	NULL
the	NULL
function	NULL
of	NULL
each	NULL
NRE-binding	NULL
factor	NULL
in	NULL
transcription	NULL
in	NULL
vivo	NULL
,	NULL
we	NULL
first	NULL
examined	NULL
the	NULL
promoter	NULL
activity	NULL
of	NULL
HIV-1	NULL
LTR	NULL
mutants	NULL
,	NULL
in	NULL
which	NULL
the	NULL
binding	NULL
sites	NULL
for	NULL
each	NULL
or	NULL
both	NULL
factors	NULL
were	NULL
disrupted	NULL
by	NULL
means	NULL
of	NULL
site-directed	NULL
mutagenesis	NULL
,	NULL
in	NULL
Jurkat	NULL
cells	NULL
using	NULL
the	NULL
CAT	NULL
assay	NULL
.	NULL

The	NULL
results	NULL
indicated	NULL
that	NULL
the	NULL
mutation	NULL
in	NULL
site	NULL
1	NULL
reproducibly	NULL
increased	NULL
the	NULL
promoter	NULL
activity	NULL
about	NULL
two-fold	NULL
and	NULL
that	NULL
the	NULL
mutation	NULL
in	NULL
site	NULL
2	NULL
did	NULL
not	NULL
significantly	NULL
affect	NULL
the	NULL
promoter	NULL
activity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
to	NULL
determine	NULL
the	NULL
function	NULL
of	NULL
each	NULL
factor	NULL
more	NULL
directly	NULL
,	NULL
we	NULL
inserted	NULL
four	NULL
copies	NULL
of	NULL
the	NULL
binding	NULL
site	NULL
for	NULL
each	NULL
factor	NULL
into	NULL
the	NULL
upstream	NULL
region	NULL
of	NULL
a	NULL
heterologous	NULL
promoter	NULL
,	NULL
which	NULL
was	NULL
derived	NULL
from	NULL
the	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
(	NULL
RSV	NULL
)	NULL
LTR	NULL
by	NULL
deleting	NULL
other	NULL
cis-elements	NULL
upstream	NULL
from	NULL
the	NULL
functional	NULL
TATA	NULL
box	NULL
and	NULL
linked	NULL
to	NULL
the	NULL
bacterial	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
gene	NULL
(	NULL
pRAU3-CAT	NULL
;	NULL
ref	NULL
.	NULL

35	NULL
)	NULL
.	NULL

Each	NULL
chimeric	NULL
promoter-CAT	NULL
construct	NULL
(	NULL
site1	NULL
X4	NULL
and	NULL
site2	NULL
X4	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
parental	NULL
plasmid	NULL
as	NULL
a	NULL
control	NULL
,	NULL
was	NULL
co-transfected	NULL
with	NULL
a	NULL
plasmid	NULL
carrying	NULL
the	NULL
B-galactosidase	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
B-actin	NULL
promoter	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
into	NULL
Jurkat	NULL
cells	NULL
by	NULL
means	NULL
of	NULL
electroporation	NULL
,	NULL
and	NULL
then	NULL
the	NULL
promoter	NULL
activity	NULL
was	NULL
determined	NULL
as	NULL
the	NULL
CAT	NULL
activity	NULL
.	NULL

The	NULL
efficiency	NULL
of	NULL
each	NULL
transfection	NULL
was	NULL
determined	NULL
as	NULL
the	NULL
B-galactosidase	NULL
activity	NULL
.	NULL

For	NULL
reproducibility	NULL
of	NULL
the	NULL
experiments	NULL
,	NULL
the	NULL
Fr4.1	NULL
Hela	NULL
NE	NULL
competitor	NULL
cold	NULL
B	NULL
APA	NULL
cold	NULL
B	NULL
APA	NULL
wt	NULL
mt	NULL
wt	NULL
mt	NULL
-	NULL
wt	NULL
mt	NULL
wt	NULL
mt	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
Figure	NULL
5	NULL
.	NULL

Examination	NULL
of	NULL
the	NULL
ability	NULL
of	NULL
binding	NULL
of	NULL
the	NULL
factor	NULL
in	NULL
Fr4.1	NULL
to	NULL
the	NULL
collagenase	NULL
enhancer	NULL
.	NULL

2	NULL
Ll	NULL
of	NULL
Fr4.1	NULL
or	NULL
5	NULL
ul	NULL
of	NULL
a	NULL
HeLa	NULL
nuclear	NULL
extract	NULL
was	NULL
incubated	NULL
with	NULL
radio-labeled	NULL
probe	NULL
B	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
non-labeled	NULL
probe	NULL
B	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
7	NULL
)	NULL
,	NULL
mt2	NULL
oligonucleotides	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
8	NULL
)	NULL
,	NULL
or	NULL
the	NULL
synthetic	NULL
collagenase	NULL
gene	NULL
enhancer	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
9	NULL
)	NULL
or	NULL
its	NULL
mutant	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
10	NULL
)	NULL
.	NULL

transfection	NULL
and	NULL
CAT	NULL
enzyme	NULL
assay	NULL
were	NULL
carried	NULL
out	NULL
three	NULL
times	NULL
,	NULL
and	NULL
each	NULL
round	NULL
of	NULL
experiments	NULL
was	NULL
carried	NULL
out	NULL
in	NULL
triplicate	NULL
.	NULL

The	NULL
CAT	NULL
conversion	NULL
rates	NULL
were	NULL
measured	NULL
by	NULL
densitometric	NULL
scanning	NULL
and	NULL
the	NULL
values	NULL
were	NULL
normalized	NULL
to	NULL
the	NULL
transfection	NULL
efficiency	NULL
.	NULL

Fig	NULL
.	NULL

6	NULL
shows	NULL
typical	NULL
results	NULL
of	NULL
the	NULL
experiments	NULL
and	NULL
clearly	NULL
demonstrates	NULL
that	NULL
the	NULL
insertion	NULL
of	NULL
four	NULL
copies	NULL
of	NULL
each	NULL
NRE-binding	NULL
factor	NULL
recognition	NULL
sequence	NULL
reduced	NULL
the	NULL
CAT	NULL
activity	NULL
.	NULL

The	NULL
normalized	NULL
reduction	NULL
rate	NULL
relative	NULL
to	NULL
the	NULL
control	NULL
was	NULL
approximately	NULL
one-tenth	NULL
for	NULL
site1X4	NULL
or	NULL
one-third	NULL
for	NULL
site2	NULL
X4	NULL
,	NULL
respectively	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
transfected	NULL
cells	NULL
with	NULL
a	NULL
phorbol	NULL
ester	NULL
or	NULL
co-transfection	NULL
with	NULL
a	NULL
Tat-expression	NULL
plasmid	NULL
did	NULL
not	NULL
cause	NULL
any	NULL
significant	NULL
change	NULL
in	NULL
the	NULL
transcriptional	NULL
suppression	NULL
by	NULL
each	NULL
factor	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
the	NULL
HIV-1	NULL
NRE	NULL
binding	NULL
factors	NULL
identified	NULL
here	NULL
act	NULL
as	NULL
suppressors	NULL
of	NULL
transcription	NULL
in	NULL
vivo	NULL
.	NULL

DISCUSSION	NULL
We	NULL
identified	NULL
two	NULL
cellular	NULL
proteins	NULL
that	NULL
bound	NULL
to	NULL
neighboring	NULL
sequences	NULL
within	NULL
HIV-1	NULL
NRE	NULL
.	NULL

When	NULL
the	NULL
binding	NULL
site	NULL
for	NULL
each	NULL
factor	NULL
was	NULL
multimerized	NULL
and	NULL
placed	NULL
upstream	NULL
of	NULL
the	NULL
TATA	NULL
box	NULL
of	NULL
RSV-LTR	NULL
,	NULL
the	NULL
promoter	NULL
activity	NULL
was	NULL
markedly	NULL
reduced	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
each	NULL
factor	NULL
can	NULL
suppress	NULL
transcription	NULL
from	NULL
a	NULL
heterologous	NULL
promoter	NULL
.	NULL

Thus	NULL
,	NULL
hereafter	NULL
,	NULL
we	NULL
refer	NULL
to	NULL
each	NULL
factor	NULL
as	NULL
a	NULL
negative	NULL
regulator	NULL
of	NULL
transcription	NULL
(	NULL
NRT	NULL
)	NULL
.	NULL

NRT-1	NULL
,	NULL
the	NULL
factor	NULL
found	NULL
in	NULL
Fr4.2	NULL
,	NULL
bound	NULL
to	NULL
a	NULL
region	NULL
containing	NULL
a	NULL
novel	NULL
dyad	NULL
symmetrical	NULL
sequence	NULL
.	NULL

This	NULL
sequence	NULL
,	NULL
comprising	NULL
18	NULL
base-pairs	NULL
(	NULL
bp	NULL
)	NULL
,	NULL
is	NULL
well	NULL
conserved	NULL
in	NULL
various	NULL
HIV-1	NULL
isolates	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
no	NULL
such	NULL
sequence	NULL
was	NULL
found	NULL
in	NULL
HIV-2	NULL
isolates	NULL
,	NULL
although	NULL
15	NULL
out	NULL
of	NULL
these	NULL
18	NULL
bp	NULL
were	NULL
found	NULL
in	NULL
the	NULL
simian	NULL
immunodeficiency	NULL
virus	NULL
isolated	NULL
from	NULL
an	NULL
African	NULL
green	NULL
monkey	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
74	NULL
%	NULL
homology	NULL
was	NULL
detected	NULL
with	NULL
-	NULL
104	NULL
to	NULL
-95	NULL
of	NULL
the	NULL
human	NULL
retinoblastoma	NULL
gene	NULL
(	NULL
RB	NULL
)	NULL
promoter	NULL
region	NULL
(	NULL
40	NULL
,	NULL
41	NULL
)	NULL
.	NULL

No	NULL
other	NULL
significant	NULL
homology	NULL
was	NULL
found	NULL
with	NULL
the	NULL
regulatory	NULL
sequences	NULL
of	NULL
other	NULL
genes	NULL
in	NULL
the	NULL
EMBL	NULL
data	NULL
base	NULL
.	NULL

Recently	NULL
,	NULL
a	NULL
bacterially	NULL
synthesized	NULL
Myb	NULL
protein	NULL
,	NULL
a	NULL
nuclear	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
Vol	NULL
.	NULL

19	NULL
,	NULL
No	NULL
.	NULL

22	NULL
6111	NULL
control	NULL
site1X4	NULL
_	NULL
site2X4	NULL
It-	NULL
-A	NULL
4	NULL
Smal	NULL
r	NULL
»	NULL
(	NULL
27082	NULL
)	NULL
‘	NULL
/	NULL
\\	NULL
©	NULL
a	NULL
a	NULL
#	NULL
#	NULL
<	NULL
©	NULL
#	NULL
BOK-	NULL
site1X4	NULL
-o	NULL
Comm	NULL
Figure	NULL
6	NULL
.	NULL

Transcriptional	NULL
repression	NULL
on	NULL
insertion	NULL
of	NULL
multiple	NULL
copies	NULL
of	NULL
the	NULL
binding	NULL
site	NULL
for	NULL
the	NULL
factor	NULL
in	NULL
Fr4.1	NULL
or	NULL
Fr4.2	NULL
.	NULL

The	NULL
constructions	NULL
of	NULL
the	NULL
plasmids	NULL
used	NULL
for	NULL
transfections	NULL
are	NULL
indicated	NULL
at	NULL
the	NULL
left	NULL
.	NULL

Four	NULL
copies	NULL
of	NULL
site	NULL
1	NULL
or	NULL
site	NULL
2	NULL
oligonucleotides	NULL
were	NULL
inserted	NULL
into	NULL
the	NULL
unique	NULL
Smal	NULL
site	NULL
of	NULL
a	NULL
plasmid	NULL
,	NULL
pRAU3-CAT	NULL
(	NULL
35	NULL
)	NULL
.	NULL

The	NULL
resultant	NULL
plasmid	NULL
,	NULL
site1X4	NULL
or	NULL
site2X4	NULL
,	NULL
respectively	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
parental	NULL
plasmid	NULL
as	NULL
a	NULL
control	NULL
,	NULL
was	NULL
co-transfected	NULL
with	NULL
a	NULL
plasmid	NULL
carrying	NULL
the	NULL
3-galactosidase	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
G-actin	NULL
promoter	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
into	NULL
Jurkat	NULL
cells	NULL
.	NULL

After	NULL
48	NULL
h	NULL
,	NULL
CAT	NULL
activity	NULL
was	NULL
measured	NULL
(	NULL
right	NULL
)	NULL
.	NULL

The	NULL
results	NULL
of	NULL
triplicate	NULL
experiments	NULL
are	NULL
presented	NULL
.	NULL

protooncogene	NULL
product	NULL
,	NULL
was	NULL
shown	NULL
to	NULL
specifically	NULL
bind	NULL
to	NULL
the	NULL
U3	NULL
region	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
(	NULL
42	NULL
)	NULL
.	NULL

The	NULL
NRT-1	NULL
binding	NULL
region	NULL
covers	NULL
this	NULL
proposed	NULL
Myb	NULL
binding	NULL
site	NULL
.	NULL

Since	NULL
the	NULL
mutations	NULL
in	NULL
probe	NULL
mt	NULL
1	NULL
,	NULL
which	NULL
did	NULL
not	NULL
bind	NULL
to	NULL
NRT-1	NULL
,	NULL
were	NULL
introduced	NULL
upstream	NULL
of	NULL
the	NULL
canonical	NULL
Myb	NULL
recognition	NULL
sequence	NULL
,	NULL
CAACTG	NULL
,	NULL
in	NULL
the	NULL
HIV-1	NULL
NRE	NULL
,	NULL
the	NULL
binding	NULL
property	NULL
of	NULL
NRT-1	NULL
seems	NULL
to	NULL
be	NULL
somewhat	NULL
different	NULL
from	NULL
that	NULL
of	NULL
Myb	NULL
.	NULL

It	NULL
has	NULL
also	NULL
been	NULL
demonstrated	NULL
that	NULL
the	NULL
scrape-loaded	NULL
recombinant	NULL
Myb	NULL
protein	NULL
in	NULL
HeLa	NULL
cells	NULL
resulted	NULL
in	NULL
the	NULL
enhancement	NULL
of	NULL
CAT	NULL
activity	NULL
controlled	NULL
by	NULL
the	NULL
stably	NULL
transfected	NULL
HIV-1	NULL
LTR	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
Myb	NULL
function	NULL
on	NULL
the	NULL
HIV-1	NULL
LTR	NULL
is	NULL
opposite	NULL
to	NULL
that	NULL
of	NULL
NRT-1	NULL
.	NULL

Differences	NULL
in	NULL
the	NULL
assay	NULL
systems	NULL
or	NULL
in	NULL
the	NULL
cell	NULL
lines	NULL
used	NULL
could	NULL
account	NULL
for	NULL
the	NULL
discrepancy	NULL
.	NULL

The	NULL
binding	NULL
site	NULL
for	NULL
NRT-2	NULL
,	NULL
the	NULL
factor	NULL
detected	NULL
in	NULL
Fr4.1	NULL
,	NULL
contained	NULL
the	NULL
recognition	NULL
sequence	NULL
of	NULL
a	NULL
mammalian	NULL
transcription	NULL
factor	NULL
,	NULL
AP-1	NULL
(	NULL
43	NULL
)	NULL
.	NULL

AP-1	NULL
is	NULL
activated	NULL
by	NULL
a	NULL
phorbol	NULL
ester	NULL
,	NULL
such	NULL
as	NULL
12-O-tetradecanoyl-phorbol-13-acetate	NULL
(	NULL
TPA	NULL
)	NULL
,	NULL
and	NULL
activates	NULL
the	NULL
transcription	NULL
from	NULL
promoters	NULL
bearing	NULL
the	NULL
consensus	NULL
sequence	NULL
,	NULL
(	NULL
G/C	NULL
)	NULL
TGACT	NULL
(	NULL
C/A	NULL
)	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Altbough	NULL
two	NULL
homologous	NULL
sequences	NULL
were	NULL
predicted	NULL
for	NULL
the	NULL
HIV-1	NULL
NRE	NULL
(	NULL
26	NULL
)	NULL
,	NULL
only	NULL
one	NULL
site	NULL
,	NULL
as	NULL
indicated	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
was	NULL
protected	NULL
from	NULL
DNase	NULL
I	NULL
digestion	NULL
by	NULL
a	NULL
partially	NULL
purified	NULL
H9/IIIB	NULL
nuclear	NULL
extract	NULL
containing	NULL
NRT-2	NULL
.	NULL

This	NULL
factor	NULL
seems	NULL
to	NULL
be	NULL
different	NULL
from	NULL
AP-1	NULL
since	NULL
it	NULL
failed	NULL
to	NULL
bind	NULL
to	NULL
a	NULL
collagenase	NULL
gene	NULL
enhancer	NULL
,	NULL
which	NULL
has	NULL
a	NULL
typical	NULL
AP-1	NULL
recognition	NULL
sequence	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
binding	NULL
site	NULL
for	NULL
this	NULL
factor	NULL
deduced	NULL
from	NULL
the	NULL
HIV-1	NULL
NRE	NULL
did	NULL
not	NULL
respond	NULL
to	NULL
stimulation	NULL
by	NULL
TPA	NULL
when	NULL
inserted	NULL
upstream	NULL
of	NULL
the	NULL
TATA	NULL
box	NULL
of	NULL
the	NULL
RSV-LTR	NULL
.	NULL

Recently	NULL
,	NULL
a	NULL
DNA	NULL
binding	NULL
protein	NULL
that	NULL
binds	NULL
to	NULL
a	NULL
similar	NULL
region	NULL
to	NULL
that	NULL
discussed	NULL
here	NULL
was	NULL
reported	NULL
by	NULL
Orchard	NULL
et	NULL
al	NULL
.	NULL

(	NULL
27	NULL
)	NULL
.	NULL

In	NULL
their	NULL
footprint	NULL
experiment	NULL
,	NULL
the	NULL
protected	NULL
region	NULL
was	NULL
found	NULL
to	NULL
contain	NULL
two	NULL
putative	NULL
AP-1	NULL
sites	NULL
in	NULL
the	NULL
HIV-1	NULL
NRE	NULL
,	NULL
unlike	NULL
in	NULL
our	NULL
case	NULL
,	NULL
where	NULL
the	NULL
protected	NULL
region	NULL
contained	NULL
only	NULL
one	NULL
of	NULL
the	NULL
two	NULL
sites	NULL
.	NULL

More	NULL
recently	NULL
,	NULL
one	NULL
plausible	NULL
explanation	NULL
for	NULL
these	NULL
differences	NULL
was	NULL
presented	NULL
by	NULL
Cooney	NULL
ert	NULL
al	NULL
.	NULL

(	NULL
28	NULL
)	NULL
.	NULL

They	NULL
reported	NULL
that	NULL
the	NULL
partially	NULL
purified	NULL
human	NULL
COUP-TF	NULL
family	NULL
could	NULL
bind	NULL
to	NULL
the	NULL
region	NULL
in	NULL
question	NULL
,	NULL
through	NULL
an	NULL
imperfect	NULL
GGTCA	NULL
palindrome	NULL
found	NULL
in	NULL
the	NULL
HIV-1	NULL
NRE	NULL
.	NULL

The	NULL
pattern	NULL
of	NULL
protection	NULL
in	NULL
their	NULL
footprint	NULL
experiment	NULL
was	NULL
also	NULL
different	NULL
from	NULL
and	NULL
narrower	NULL
than	NULL
that	NULL
of	NULL
Orchard	NULL
et	NULL
al	NULL
.	NULL

Since	NULL
the	NULL
DNA	NULL
probes	NULL
employed	NULL
by	NULL
6112	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
Vol	NULL
.	NULL

19	NULL
,	NULL
No	NULL
.	NULL

22	NULL
these	NULL
two	NULL
groups	NULL
were	NULL
prepared	NULL
from	NULL
different	NULL
HIV-1	NULL
isolates	NULL
,	NULL
DNA	NULL
sequence	NULL
polymorphism	NULL
existed	NULL
.	NULL

It	NULL
was	NULL
assumed	NULL
that	NULL
A	NULL
to	NULL
G	NULL
sequence	NULL
polymorphism	NULL
at	NULL
position	NULL
-347	NULL
yielded	NULL
a	NULL
perfect	NULL
GGTCA	NULL
palindrome	NULL
in	NULL
the	NULL
sequence	NULL
employed	NULL
by	NULL
Orchard	NULL
et	NULL
al	NULL
.	NULL

,	NULL
resulting	NULL
in	NULL
a	NULL
stronger	NULL
and	NULL
wider	NULL
footprint	NULL
than	NULL
that	NULL
of	NULL
Cooney	NULL
et	NULL
al	NULL
.	NULL

(	NULL
28	NULL
)	NULL
.	NULL

Since	NULL
we	NULL
used	NULL
the	NULL
imperfect	NULL
version	NULL
,	NULL
our	NULL
footprint	NULL
was	NULL
very	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
Cooney	NULL
et	NULL
al	NULL
.	NULL

Moreover	NULL
,	NULL
our	NULL
observation	NULL
of	NULL
an	NULL
apparent	NULL
difference	NULL
in	NULL
the	NULL
mobilities	NULL
of	NULL
the	NULL
protein-DNA	NULL
complexes	NULL
detected	NULL
in	NULL
T	NULL
cell	NULL
lines	NULL
and	NULL
HeLa	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
was	NULL
consistent	NULL
with	NULL
the	NULL
result	NULL
of	NULL
Cooney	NULL
et	NULL
al	NULL
.	NULL

(	NULL
28	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
proposed	NULL
NRT-2	NULL
might	NULL
be	NULL
a	NULL
member	NULL
of	NULL
the	NULL
COUP-TF	NULL
family	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

What	NULL
are	NULL
the	NULL
roles	NULL
of	NULL
NRT-1	NULL
and	NULL
NRT	NULL
-2	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
HIV-1	NULL
expression	NULL
?	NULL

The	NULL
results	NULL
reported	NULL
here	NULL
clearly	NULL
demonstrated	NULL
the	NULL
transcriptional	NULL
repression	NULL
by	NULL
the	NULL
individual	NULL
factors	NULL
.	NULL

Recently	NULL
,	NULL
a	NULL
mutant	NULL
provirus	NULL
of	NULL
HIV-1	NULL
which	NULL
carries	NULL
a	NULL
selective	NULL
deletion	NULL
of	NULL
the	NULL
NFAT	NULL
site	NULL
(	NULL
29	NULL
)	NULL
or	NULL
the	NULL
USF	NULL
site	NULL
(	NULL
19	NULL
,	NULL
30	NULL
)	NULL
within	NULL
the	NULL
LTR	NULL
was	NULL
shown	NULL
to	NULL
replicate	NULL
more	NULL
rapidly	NULL
than	NULL
the	NULL
parental	NULL
virus	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
respectively	NULL
(	NULL
31	NULL
)	NULL
.	NULL

In	NULL
this	NULL
experiment	NULL
,	NULL
there	NULL
was	NULL
apparently	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
deletion	NULL
of	NULL
the	NULL
AP-1	NULL
site	NULL
in	NULL
which	NULL
the	NULL
complete	NULL
NRT	NULL
-2	NULL
site	NULL
and	NULL
three	NULL
nucleotides	NULL
from	NULL
the	NULL
5'-end	NULL
of	NULL
the	NULL
NRT-1	NULL
site	NULL
were	NULL
included	NULL
.	NULL

Because	NULL
the	NULL
transcriptional	NULL
repression	NULL
activity	NULL
of	NULL
NRT-2	NULL
was	NULL
weaker	NULL
than	NULL
that	NULL
of	NULL
NRT-1	NULL
,	NULL
the	NULL
deletion	NULL
might	NULL
not	NULL
reveal	NULL
an	NULL
apparent	NULL
phenotypic	NULL
change	NULL
in	NULL
their	NULL
system	NULL
.	NULL

Although	NULL
the	NULL
individual	NULL
functions	NULL
of	NULL
these	NULL
factors	NULL
remain	NULL
to	NULL
be	NULL
determined	NULL
in	NULL
detail	NULL
,	NULL
our	NULL
observation	NULL
that	NULL
NRT-1	NULL
and	NULL
NRT-2	NULL
can	NULL
serve	NULL
as	NULL
negative	NULL
regulators	NULL
of	NULL
transcription	NULL
under	NULL
certain	NULL
circumstances	NULL
should	NULL
provide	NULL
a	NULL
basis	NULL
for	NULL
understanding	NULL
the	NULL
mechanism	NULL
of	NULL
negative	NULL
regulation	NULL
of	NULL
HIV-1	NULL
transcription	NULL
through	NULL
the	NULL
NRE	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
wish	NULL
to	NULL
thank	NULL
Mr	NULL
Hiroaki	NULL
Ono	NULL
for	NULL
his	NULL
help	NULL
in	NULL
the	NULL
cell	NULL
cultures	NULL
and	NULL
Mr	NULL
Masato	NULL
Shimizu	NULL
for	NULL
his	NULL
help	NULL
in	NULL
the	NULL
oligonucleotide	NULL
synthesis	NULL
.	NULL

The	NULL
synthesis	NULL
of	NULL
oligonucleotides	NULL
was	NULL
carried	NULL
out	NULL
at	NULL
the	NULL
Research	NULL
Center	NULL
for	NULL
Protein	NULL
Engineering	NULL
of	NULL
the	NULL
Institute	NULL
for	NULL
Protein	NULL
Research	NULL
,	NULL
Osaka	NULL
University	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Drs	NULL
Makoto	NULL
Hijikata	NULL
and	NULL
Masahiro	NULL
Shirakawa	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
and	NULL
the	NULL
helpful	NULL
discussions	NULL
.	NULL

We	NULL
are	NULL
also	NULL
grateful	NULL
to	NULL
Dr	NULL
Shunsuke	NULL
Ishii	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
and	NULL
the	NULL
comments	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
Grants-in-Aids	NULL
from	NULL
the	NULL
Ministry	NULL
of	NULL
Education	NULL
,	NULL
Science	NULL
and	NULL
Culture	NULL
,	NULL
and	NULL
the	NULL
Ministry	NULL
of	NULL
Health	NULL
and	NULL
Welfare	NULL
of	NULL
Japan	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Barre-Sinoussi	NULL
,	NULL
F.	NULL
,	NULL
Chermann	NULL
,	NULL
J.C.	NULL
,	NULL
Rey	NULL
,	NULL
F.	NULL
,	NULL
Nugeyre.M.T	NULL
.	NULL

,	NULL
Chamaret	NULL
,	NULL
S.	NULL
,	NULL
Gruest	NULL
,	NULL
J.	NULL
,	NULL
Dauguet	NULL
,	NULL
C.	NULL
,	NULL
Axler-Blin	NULL
,	NULL
C.	NULL
,	NULL
Vezinet-Brun	NULL
,	NULL
F.	NULL
,	NULL
Rouzioux	NULL
,	NULL
C.	NULL
,	NULL
Rozenbaum	NULL
,	NULL
W.	NULL
and	NULL
Montagnier	NULL
,	NULL
L	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
Science	NULL
220	NULL
,	NULL
868-871	NULL
.	NULL

2	NULL
.	NULL

Gallo	NULL
,	NULL
R.C	NULL
.	NULL

,	NULL
Salahuddin	NULL
,	NULL
$	NULL
.Z	NULL
.	NULL

,	NULL
Popovic	NULL
,	NULL
M.	NULL
,	NULL
Shearer	NULL
,	NULL
G.M	NULL
.	NULL

,	NULL
Kaplan	NULL
,	NULL
M.	NULL
,	NULL
Haynes	NULL
,	NULL
B.F.	NULL
,	NULL
Palker	NULL
,	NULL
T.J.	NULL
,	NULL
Redfield	NULL
,	NULL
R.	NULL
,	NULL
Oleske	NULL
,	NULL
J.	NULL
,	NULL
Safai	NULL
,	NULL
B.	NULL
,	NULL
White	NULL
,	NULL
G.	NULL
,	NULL
Foster	NULL
,	NULL
P	NULL
.	NULL

and	NULL
Markham	NULL
,	NULL
P.D	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
Science	NULL
224	NULL
,	NULL
500-503	NULL
.	NULL

3	NULL
.	NULL

Fauci	NULL
,	NULL
A.S	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Science	NULL
239	NULL
,	NULL
617-622	NULL
.	NULL

4	NULL
.	NULL

Varmus	NULL
,	NULL
H	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

2	NULL
,	NULL
1055-1062	NULL
.	NULL

5	NULL
.	NULL

Cullen	NULL
,	NULL
B.R	NULL
.	NULL

and	NULL
Greene	NULL
,	NULL
W.C.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
58	NULL
,	NULL
423-426	NULL
.	NULL

6	NULL
.	NULL

Rosen	NULL
,	NULL
C.A	NULL
.	NULL

,	NULL
Sodroski	NULL
,	NULL
J.G	NULL
.	NULL

and	NULL
Haseltine	NULL
,	NULL
W.	NULL
A	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
Cell	NULL
41	NULL
,	NULL
813-823	NULL
.	NULL

7	NULL
.	NULL

23:1	NULL
;	NULL
ng	NULL
Guo	NULL
,	NULL
C.	NULL
,	NULL
Josephs	NULL
,	NULL
S.F	NULL
.	NULL

and	NULL
Wong-Staal	NULL
,	NULL
F	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
Science	NULL
229	NULL
,	NULL
8	NULL
.	NULL

Sodroski	NULL
,	NULL
J.	NULL
,	NULL
Patarca	NULL
,	NULL
R.	NULL
,	NULL
Rosen	NULL
,	NULL
C.	NULL
,	NULL
Wong-Staal	NULL
,	NULL
F	NULL
.	NULL

and	NULL
Haseltine	NULL
,	NULL
W.	NULL
(	NULL
1985	NULL
)	NULL
Science	NULL
229	NULL
,	NULL
74-77	NULL
.	NULL

9	NULL
.	NULL

Peterlin	NULL
,	NULL
B.M	NULL
.	NULL

,	NULL
Luciw	NULL
,	NULL
P	NULL
.	NULL

A.	NULL
,	NULL
Barr	NULL
,	NULL
P.J	NULL
.	NULL

and	NULL
Walker	NULL
,	NULL
M.D	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
83	NULL
,	NULL
9734-9738	NULL
.	NULL

10	NULL
.	NULL

Rosen	NULL
,	NULL
C.A	NULL
.	NULL

,	NULL
Sodroski	NULL
,	NULL
J.G	NULL
.	NULL

,	NULL
Goh	NULL
,	NULL
Dayton	NULL
,	NULL
A.I	NULL
.	NULL

,	NULL
Lippke	NULL
,	NULL
J	NULL
.	NULL

and	NULL
Haseltine	NULL
,	NULL
W.	NULL
A	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Nature	NULL
319	NULL
,	NULL
555-559	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20.	NULL
.	NULL

Wu	NULL
,	NULL
F.K	NULL
.	NULL

,	NULL
Garcia	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Harrich	NULL
,	NULL
D	NULL
.	NULL

and	NULL
Gaynor	NULL
,	NULL
R.B	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

7	NULL
,	NULL
22	NULL
.	NULL

23	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

35°	NULL
Maxam	NULL
,	NULL
A.M	NULL
.	NULL

and	NULL
Gilbert	NULL
,	NULL
W.	NULL
(	NULL
1980	NULL
)	NULL
Methods	NULL
Enzymol	NULL
.	NULL

65	NULL
,	NULL
499-560	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43.	NULL
.	NULL

Muesing.M.A	NULL
.	NULL

,	NULL
Smith	NULL
,	NULL
D.H	NULL
.	NULL

and	NULL
Capon	NULL
,	NULL
D.J	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Cell	NULL
48	NULL
,	NULL
691-701.	NULL
.	NULL

Hauber	NULL
,	NULL
J	NULL
.	NULL

and	NULL
Cullen	NULL
,	NULL
B.R	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

62	NULL
,	NULL
673-679.	NULL
.	NULL

Tong-Starksen	NULL
,	NULL
S.E	NULL
.	NULL

,	NULL
Luciw	NULL
,	NULL
P	NULL
.	NULL

A.	NULL
and	NULL
Peterlin	NULL
,	NULL
B.M	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84	NULL
,	NULL
6845-6849	NULL
.	NULL

Kaufman	NULL
,	NULL
J.D	NULL
.	NULL

,	NULL
Valandra	NULL
,	NULL
G.	NULL
,	NULL
Roderiquez	NULL
,	NULL
G.	NULL
,	NULL
Bushar	NULL
,	NULL
G.	NULL
,	NULL
Giri	NULL
,	NULL
C	NULL
.	NULL

and	NULL
Norcross	NULL
,	NULL
M.A	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7	NULL
,	NULL
3759-3766	NULL
.	NULL

Nabel	NULL
,	NULL
G	NULL
.	NULL

and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1987	NULL
)	NULL
Nature	NULL
326	NULL
,	NULL
711-713	NULL
.	NULL

Siekevitz	NULL
,	NULL
M.	NULL
,	NULL
Josephs	NULL
,	NULL
S.F	NULL
.	NULL

,	NULL
Dukovich	NULL
,	NULL
M.	NULL
,	NULL
Peffer	NULL
,	NULL
N.	NULL
,	NULL
Wong-Staal	NULL
,	NULL
F	NULL
.	NULL

and	NULL
Greene	NULL
,	NULL
W.C.	NULL
(	NULL
1987	NULL
)	NULL
Science	NULL
238	NULL
,	NULL
1575-1578	NULL
.	NULL

Griffin	NULL
,	NULL
G.E	NULL
.	NULL

,	NULL
Leung.K	NULL
.	NULL

,	NULL
Folks	NULL
,	NULL
T.M	NULL
.	NULL

,	NULL
Kunkel	NULL
,	NULL
S	NULL
.	NULL

and	NULL
Nabel	NULL
,	NULL
G.J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Nature	NULL
339	NULL
,	NULL
70-73	NULL
.	NULL

Lu	NULL
,	NULL
Y.	NULL
,	NULL
Stenzel	NULL
,	NULL
M.	NULL
,	NULL
Sodroski	NULL
,	NULL
J.G	NULL
.	NULL

and	NULL
Haseltine	NULL
,	NULL
W.	NULL
A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

63	NULL
,	NULL
4115-4119	NULL
.	NULL

Garcia	NULL
,	NULL
)	NULL
.	NULL

A.	NULL
,	NULL
Wu	NULL
,	NULL
F.K	NULL
.	NULL

,	NULL
Mitsuyasu	NULL
,	NULL
R	NULL
.	NULL

and	NULL
Gaynor	NULL
,	NULL
R.B	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

6	NULL
,	NULL
3761-3770	NULL
.	NULL

Jones	NULL
,	NULL
K	NULL
.	NULL

A.	NULL
,	NULL
Luciw	NULL
,	NULL
P	NULL
.	NULL

A.	NULL
and	NULL
Duchange	NULL
,	NULL
N	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

2	NULL
,	NULL
1101-1114	NULL
.	NULL

2117-2129	NULL
.	NULL

Garcia	NULL
,	NULL
J.A	NULL
.	NULL

,	NULL
Harrich	NULL
,	NULL
D.	NULL
,	NULL
Soultanakis	NULL
,	NULL
E.	NULL
,	NULL
Wu	NULL
,	NULL
F.	NULL
,	NULL
Mitsuyasu	NULL
,	NULL
R	NULL
.	NULL

and	NULL
Gaynor	NULL
,	NULL
R.B	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8	NULL
,	NULL
765-778	NULL
.	NULL

Kawakami	NULL
,	NULL
K.	NULL
,	NULL
Scheidereit	NULL
,	NULL
C	NULL
.	NULL

and	NULL
Roeder	NULL
,	NULL
R.G	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85	NULL
,	NULL
4700-4704.	NULL
.	NULL

Maekawa	NULL
,	NULL
T.	NULL
,	NULL
Itoh	NULL
,	NULL
F.	NULL
,	NULL
Okamoto	NULL
,	NULL
T.	NULL
,	NULL
Kurimoto	NULL
,	NULL
M.	NULL
,	NULL
Imamoto	NULL
,	NULL
F	NULL
.	NULL

and	NULL
Ishii	NULL
,	NULL
S	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264	NULL
,	NULL
2826-2831	NULL
.	NULL

Dinter	NULL
,	NULL
H.	NULL
,	NULL
Chiu	NULL
,	NULL
R.	NULL
,	NULL
Imagawa	NULL
,	NULL
M.	NULL
,	NULL
Karin	NULL
,	NULL
M.	NULL
and	NULL
Jones	NULL
,	NULL
K.A	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

6	NULL
,	NULL
4067-4071	NULL
.	NULL

Franza	NULL
,	NULL
B.R	NULL
.	NULL

Jr	NULL
,	NULL
Rauscher	NULL
,	NULL
F.J.	NULL
,	NULL
IM	NULL
,	NULL
Josephs	NULL
,	NULL
S.F	NULL
.	NULL

and	NULL
Curran	NULL
,	NULL
T	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Science	NULL
239	NULL
,	NULL
1150-1153	NULL
.	NULL

Orchard	NULL
,	NULL
K.	NULL
,	NULL
Perkins	NULL
,	NULL
N.	NULL
,	NULL
Chapman	NULL
,	NULL
C.	NULL
,	NULL
Harris	NULL
,	NULL
J.	NULL
,	NULL
Emery	NULL
,	NULL
V.	NULL
,	NULL
Goodwin	NULL
,	NULL
G.	NULL
,	NULL
Latchman	NULL
,	NULL
D	NULL
.	NULL

and	NULL
Collins	NULL
,	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

64	NULL
,	NULL
3234-3239	NULL
.	NULL

Cooney	NULL
,	NULL
A.J	NULL
.	NULL

,	NULL
Tsai	NULL
,	NULL
S.Y	NULL
.	NULL

,	NULL
O'Malley	NULL
,	NULL
B.W	NULL
.	NULL

and	NULL
Tsai	NULL
,	NULL
M.-J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

65	NULL
,	NULL
2853-2860	NULL
.	NULL

Shaw	NULL
,	NULL
J.-P.	NULL
,	NULL
Utz	NULL
,	NULL
P.J	NULL
.	NULL

,	NULL
Durand	NULL
,	NULL
D.B	NULL
.	NULL

,	NULL
Toole	NULL
,	NULL
J.J.	NULL
,	NULL
Emmel	NULL
,	NULL
E.A	NULL
.	NULL

and	NULL
Crabtree	NULL
,	NULL
G.R	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Science	NULL
241	NULL
,	NULL
202-205	NULL
.	NULL

Carthew	NULL
,	NULL
R.W	NULL
.	NULL

,	NULL
Chodosh	NULL
,	NULL
L.A	NULL
.	NULL

and	NULL
Sharp	NULL
,	NULL
P.A	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
Cell	NULL
43	NULL
,	NULL
439-448	NULL
.	NULL

Lu	NULL
,	NULL
Y.	NULL
,	NULL
Touzjian	NULL
,	NULL
N.	NULL
,	NULL
Stenzel.M	NULL
.	NULL

,	NULL
Dorfman	NULL
,	NULL
T.	NULL
,	NULL
Sodroski	NULL
,	NULL
J.G	NULL
.	NULL

and	NULL
Haseltine	NULL
,	NULL
W.	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

64	NULL
,	NULL
5226-5229	NULL
.	NULL

Dignam	NULL
,	NULL
J.D	NULL
.	NULL

,	NULL
Lebovitz	NULL
,	NULL
R.M	NULL
.	NULL

and	NULL
Roeder	NULL
,	NULL
R.G	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11	NULL
,	NULL
1475-1489	NULL
.	NULL

Okamoto	NULL
,	NULL
T.	NULL
and	NULL
Wong-Staal	NULL
,	NULL
F	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Cell	NULL
47	NULL
,	NULL
29-35	NULL
.	NULL

Shimotohno	NULL
,	NULL
K.	NULL
,	NULL
Takano	NULL
,	NULL
M.	NULL
,	NULL
Teruuchi	NULL
,	NULL
T	NULL
.	NULL

and	NULL
Miwa	NULL
,	NULL
M.	NULL
(	NULL
1986	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
83	NULL
,	NULL
8112-8116	NULL
.	NULL

Mori	NULL
,	NULL
S.	NULL
,	NULL
Takada	NULL
,	NULL
R.	NULL
,	NULL
Shimotohno	NULL
,	NULL
K	NULL
.	NULL

and	NULL
Okamoto	NULL
,	NULL
T.	NULL
(	NULL
1990	NULL
)	NULL
Jpn	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

81	NULL
,	NULL
1124-1131	NULL
.	NULL

Gorman	NULL
,	NULL
C	NULL
.	NULL

M.	NULL
,	NULL
Moffat	NULL
,	NULL
L.F	NULL
.	NULL

and	NULL
Howard	NULL
,	NULL
B.H	NULL
.	NULL

(	NULL
1982	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

2	NULL
,	NULL
1044-1051	NULL
.	NULL

Angel	NULL
,	NULL
P.	NULL
,	NULL
Imagawa	NULL
,	NULL
M.	NULL
,	NULL
Chiu	NULL
,	NULL
R.	NULL
,	NULL
Stein	NULL
,	NULL
B.	NULL
,	NULL
Imbra	NULL
,	NULL
R.J.	NULL
,	NULL
Rahmsdorf	NULL
,	NULL
H.J	NULL
.	NULL

,	NULL
«	NULL
Jonat	NULL
,	NULL
C.	NULL
,	NULL
Herrlich	NULL
,	NULL
P	NULL
.	NULL

and	NULL
Karin	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Cell	NULL
49	NULL
,	NULL
729-739	NULL
.	NULL

Fukasawa	NULL
,	NULL
M.	NULL
,	NULL
Miura	NULL
,	NULL
T.	NULL
,	NULL
Hasegawa	NULL
,	NULL
A.	NULL
,	NULL
Morikawa	NULL
,	NULL
S.	NULL
,	NULL
Tsujimoto	NULL
,	NULL
H.	NULL
,	NULL
Miki	NULL
,	NULL
K.	NULL
,	NULL
Kitamura	NULL
,	NULL
T	NULL
.	NULL

and	NULL
Hayami	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Nature	NULL
333	NULL
,	NULL
457-461.	NULL
.	NULL

Hong	NULL
,	NULL
F.D	NULL
.	NULL

,	NULL
Huang	NULL
,	NULL
H.-J.S	NULL
.	NULL

,	NULL
To	NULL
,	NULL
H.	NULL
,	NULL
Young	NULL
.	NULL

,	NULL
L.-J.S	NULL
.	NULL

,	NULL
Oro	NULL
,	NULL
A.	NULL
,	NULL
Bookstein	NULL
,	NULL
R.	NULL
,	NULL
Lee	NULL
,	NULL
E.Y.-H.P	NULL
.	NULL

and	NULL
Lee	NULL
,	NULL
W.-H.	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86	NULL
,	NULL
5502-5506	NULL
.	NULL

McGee	NULL
,	NULL
T.L	NULL
.	NULL

,	NULL
Yandell	NULL
,	NULL
D.W	NULL
.	NULL

and	NULL
Dryja	NULL
,	NULL
T.P	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Gene	NULL
80	NULL
,	NULL
119-128	NULL
.	NULL

Dasgupta	NULL
,	NULL
P.	NULL
,	NULL
Saikumar	NULL
,	NULL
P.	NULL
,	NULL
Reddy	NULL
,	NULL
C	NULL
.	NULL

M.	NULL
and	NULL
Reddy	NULL
,	NULL
E.P	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87	NULL
,	NULL
8090-8094	NULL
.	NULL

Lee	NULL
,	NULL
W.	NULL
,	NULL
Haslinger	NULL
,	NULL
A.	NULL
,	NULL
Karin	NULL
,	NULL
M.	NULL
and	NULL
Tjian	NULL
,	NULL
R	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Nature	NULL
325	NULL
,	NULL
368-372	NULL
.	NULL

